3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
86
Recurrence
18
Neoplasms
6
Neoplasms, Plasma Cell
3
Lymphoma, Non-Hodgkin
3
Sarcoma, Kaposi
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Immunoglobulin Light-chain Amyloidosis
2
Chromosome 17 deletion
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
Waldenstrom Macroglobulinemia
1
Smoldering Multiple Myeloma
1
Proteostasis Deficiencies
1
Plasmacytoma
1
Plasmablastic Lymphoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Malignant Plasma Cell Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myelomonocytic, Chronic
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Epstein-Barr Virus Infections
1
Interventions
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
7
X-Rays
6
Temozolomide
6
Specimen Handling
6
Phantoms, Imaging
6
Biopsy
6
Nuclear Medicine Department, Hospital
5
Etoposide
5
Nivolumab
4
Bevacizumab
4
Radiation
3
Irinotecan
3
Automobiles
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
lutetium Lu 177 dotatate
2
larotrectinib
2
ivosidenib
2
etoposide phosphate
2
erdafitinib
2
ensartinib
2
abemaciclib
2
Watchful Waiting
2
Radiotherapy
2
ONC206
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ependymoma
×
pomalidomide
×
1 year
×
Clear all
No trials found.